Abiopharma

🔍 Adnani Amir (Director)

Company: URANIUM ENERGY CORP (UEC)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 185,000 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: G | equity_swap_involved: 0 | shares_owned_after: 927,905.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 421,795 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,820,668.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 225,661 shares of Common Stock at $9.6 per share (Direct)
  Date: 2026-07-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,595,007.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 132,240 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,727,247.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 71,094 shares of Common Stock at $9.6 per share (Direct)
  Date: 2026-07-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,656,153.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 110,227 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,766,380.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 58,972 shares of Common Stock at $9.6 per share (Direct)
  Date: 2026-07-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,707,408.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 132,564 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,839,972.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 70,922 shares of Common Stock at $9.6 per share (Direct)
  Date: 2026-07-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 4,769,050.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 564,682 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,292,409.00 | transaction_form_type: 4 | Footnotes: F5, F6, F7, F7
• Sold 132,240 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,160,169.00 | transaction_form_type: 4 | Footnotes: F5, F8, F8
• Sold 110,227 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,049,942.00 | transaction_form_type: 4 | Footnotes: F5, F8, F8
• Sold 132,564 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 917,378.00 | transaction_form_type: 4 | Footnotes: F5, F8, F8
• Sold 540,984 shares of Performance Based Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F9, F9, F10

Footnotes:

• F1: Represents donation to charitable organizations of shares of common stock. These charitable gifts consisted of shares of common stock that were indirectly owned by the reporting person through Amir Adnani Corp., his wholly-owned and controlled subsidiary.
• F2: Amir Adnani Corp. is wholly-owned and controlled by the reporting person. Accordingly, all of the shares of common stock held by Amir Adnani Corp. may be deemed to be beneficially held by the reporting person.
• F3: This transaction represents the settlement of Performance Based Restricted Stock Units in shares of common stock on their scheduled vesting date. Each Performance Based Restricted Stock Unit represents a contingent right to receive one share of common stock.
• F4: Represents shares of common stock withheld to satisfy tax withholding requirements upon vesting of Performance Based Restricted Stock Units and Restricted Stock Units (as applicable).
• F5: Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
• F6: Granted pursuant to and in accordance with the 2024 Stock Incentive Plan.
• F7: The Restricted Stock Units vest in three equal instalments beginning July 31, 2027. Vested shares will be delivered to the reporting person no later than August 30th of each year.
• F8: This award vested as to one-third of the Restricted Stock Units on the first, second and third anniversary of the grant date.
• F9: This award vested on the third anniversary of the grant date.
• F10: This figure reflects that all Performance Based Restricted Stock Units voluntarily reported on prior Form 4 filings by the reporting person have settled as of the date hereof.